4 studies found for:    20921465 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases resection;   Drug: Bevacizumab;   Drug: 5 FU;   Drug: Oxaliplatin;   Drug: Irinotecan
2 Completed
Has Results
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: FOLFOX regimen
3 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases Resection ( multiple steep surgery possible);   Drug: 5-Fluorouracile;   Drug: leucovorin L;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Cetuximab
4 Completed FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer
Condition: Metastatic Colo-rectal Cancer
Intervention: Drug: FOLFOXIRI + Panitumumab

Indicates status has not been verified in more than two years